Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer

Shuya Yano; Motoki Ninomiya; Hiroshi Sasaki; Tatsuo Umeoka; Masao Harano; Hideki Aoki; Tadashi Onoda; Shigehiro Shiozaki; Satoshi Ohno; Kenji Higaki; Norihisa Takakura

Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer

Shuya Yano, Motoki Ninomiya, Hiroshi Sasaki, Tatsuo Umeoka, Masao Harano, Hideki Aoki, Tadashi Onoda, Shigehiro Shiozaki, Satoshi Ohno, Kenji Higaki, Norihisa Takakura

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

We studied the significance of repeated intraperitoneal CDDP administration, as adjuvant chemotherapy, for the prevention of T3 and T4 gastric cancer. Fifty-two patients who had been operated as Curability B were divided into the following two groups, and the data on survival rate, median survival time and interval of "free of recurrence" were accumulated and analyzed. Group A consisted of nineteen patients treated with intraperitoneal CDDP administration and oral anticancer drugs. Group B were treated with systemic chemotherapy. Group A was superior to Group B in comparing the analyzed data. These results suggested that repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 advanced gastric cancer would improve survival rate.

Original language	English
Pages (from-to)	1720-1722
Number of pages	3
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	31
Issue number	11
Publication status	Published - Oct 2004
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{9c1f27b50658432cbbf9ea9a0c896afd,

title = "Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer",

abstract = "We studied the significance of repeated intraperitoneal CDDP administration, as adjuvant chemotherapy, for the prevention of T3 and T4 gastric cancer. Fifty-two patients who had been operated as Curability B were divided into the following two groups, and the data on survival rate, median survival time and interval of {"}free of recurrence{"} were accumulated and analyzed. Group A consisted of nineteen patients treated with intraperitoneal CDDP administration and oral anticancer drugs. Group B were treated with systemic chemotherapy. Group A was superior to Group B in comparing the analyzed data. These results suggested that repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 advanced gastric cancer would improve survival rate.",

author = "Shuya Yano and Motoki Ninomiya and Hiroshi Sasaki and Tatsuo Umeoka and Masao Harano and Hideki Aoki and Tadashi Onoda and Shigehiro Shiozaki and Satoshi Ohno and Kenji Higaki and Norihisa Takakura",

year = "2004",

month = oct,

language = "English",

volume = "31",

pages = "1720--1722",

journal = "Japanese Journal of Cancer and Chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "11",

}

TY - JOUR

T1 - Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer

AU - Yano, Shuya

AU - Ninomiya, Motoki

AU - Sasaki, Hiroshi

AU - Umeoka, Tatsuo

AU - Harano, Masao

AU - Aoki, Hideki

AU - Onoda, Tadashi

AU - Shiozaki, Shigehiro

AU - Ohno, Satoshi

AU - Higaki, Kenji

AU - Takakura, Norihisa

PY - 2004/10

Y1 - 2004/10

N2 - We studied the significance of repeated intraperitoneal CDDP administration, as adjuvant chemotherapy, for the prevention of T3 and T4 gastric cancer. Fifty-two patients who had been operated as Curability B were divided into the following two groups, and the data on survival rate, median survival time and interval of "free of recurrence" were accumulated and analyzed. Group A consisted of nineteen patients treated with intraperitoneal CDDP administration and oral anticancer drugs. Group B were treated with systemic chemotherapy. Group A was superior to Group B in comparing the analyzed data. These results suggested that repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 advanced gastric cancer would improve survival rate.

AB - We studied the significance of repeated intraperitoneal CDDP administration, as adjuvant chemotherapy, for the prevention of T3 and T4 gastric cancer. Fifty-two patients who had been operated as Curability B were divided into the following two groups, and the data on survival rate, median survival time and interval of "free of recurrence" were accumulated and analyzed. Group A consisted of nineteen patients treated with intraperitoneal CDDP administration and oral anticancer drugs. Group B were treated with systemic chemotherapy. Group A was superior to Group B in comparing the analyzed data. These results suggested that repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 advanced gastric cancer would improve survival rate.

UR - http://www.scopus.com/inward/record.url?scp=16544369819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544369819&partnerID=8YFLogxK

M3 - Article

C2 - 15553694

AN - SCOPUS:16544369819

SN - 0385-0684

VL - 31

SP - 1720

EP - 1722

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

IS - 11

ER -

Effects of repeated intraperitoneal CDDP chemotherapy for the prevention of T3 and T4 gastric cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this